Patents by Inventor Richard I. Feldman

Richard I. Feldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hip kinase for fertility control
    Publication number: 20090238836
    Abstract: The present invention relates to the use of a pharmaceutical composition which comprises as active component at least one HipK4 nucleic acid, a HipK4 polypeptide, modulators of HipK4, antibodies directed against HipK4, a HipK4 antisense, and a HipK4 RNAi, for the diagnosis and treatment of fertility impairments and for contraception. The invention further relates to the use of this pharmaceutical composition for manufacturing a medicament for the treatment of fertility impairments.
    Type: Application
    Filed: August 9, 2007
    Publication date: September 24, 2009
    Inventors: FRANK SACHER, MARTIN FRITSCH, RICHARD I. FELDMAN, CARSTEN MOLLER
  • Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
    Patent number: 7504410
    Abstract: This invention relates to pyrimidine derivatives of general formula (I) as inhibitors of kinases, their production as well as their use as medications for treating various diseases.
    Type: Grant
    Filed: November 28, 2003
    Date of Patent: March 17, 2009
    Assignee: Schering Aktiengesellschaft
    Inventors: Judi Bryant, Monica J. Kochanny, Shendong Yuan, Seock-Kyu Khim, Brad O. Buckman, Damian O. Arnaiz, Ulf Bomer, Hans Briem, Peter Esperling, Christoph Huwe, Joachim Kuhnke, Martina Schafer, Lars Wortmann, Dirk Kosemund, Emil Eckle, Richard I. Feldman, Gary B. Phillips
  • Assays for identifiying compounds that bind to the gastrin releasing peptide receptor
    Patent number: 5741651
    Abstract: The invention discloses a procedure for the preparation of the solubilized and purified gastrin releasing peptide receptor, in an active form, from a gastrin releasing peptide receptor source such as Swiss 3T3 fibroblasts. The invention also discloses a method of using the solubilized gastrin releasing peptide receptor in drug screening assays to identify compounds having suitable binding affinity for the gastrin releasing peptide receptor.
    Type: Grant
    Filed: January 26, 1994
    Date of Patent: April 21, 1998
    Assignee: Berlex Biosciences
    Inventors: Richard I. Feldman, James C. Jenson
  • Solubilization and purification of the active gastrin releasing peptide receptor
    Patent number: 5591831
    Abstract: A procedure for the preparation of the solubilized and purified gastrin releasing peptide receptor, in an active form, from a gastrin releasing peptide receptor source such as Swiss 3T3 fibroblasts.
    Type: Grant
    Filed: January 25, 1994
    Date of Patent: January 7, 1997
    Assignee: Berlex Laboratories, Inc.
    Inventors: Richard I. Feldman, James M. Wu, Elaina Mann, Anne Larocca, James C. Jenson
  • Solubilization and purification of the active gastrin releasing peptide receptor
    Patent number: 5215963
    Abstract: A procedure for the preparation of the solubilized and purified gastrin releasing peptide receptor, in an active form, from a gastrin releasing peptide receptor source such as Swiss 3T3 fibroblasts.
    Type: Grant
    Filed: October 24, 1989
    Date of Patent: June 1, 1993
    Assignee: Berlex Laboratories, Inc.
    Inventors: Richard I. Feldman, James M. Wu, Elaina Mann, Anne Larocca, James C. Jenson